Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. SUVEN LIFE SCIENCES GENNEX LAB./
SUVEN LIFE SCIENCES
 
P/E (TTM) x 35.0 -20.5 - View Chart
P/BV x 4.5 5.8 77.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENNEX LAB.   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
SUVEN LIFE SCIENCES
Mar-23
GENNEX LAB./
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs994 9.7%   
Low Rs545 10.7%   
Sales per share (Unadj.) Rs3.40.6 541.2%  
Earnings per share (Unadj.) Rs0.3-5.4 -5.1%  
Cash flow per share (Unadj.) Rs0.3-5.1 -6.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs4.517.2 26.4%  
Shares outstanding (eoy) m176.64218.07 81.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.1111.8 1.9%   
Avg P/E ratio x25.0-12.8 -195.1%  
P/CF ratio (eoy) x21.0-13.5 -155.3%  
Price / Book Value ratio x1.54.0 37.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,22915,131 8.1%   
No. of employees `000NANA-   
Total wages/salary Rs m79186 42.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m593135 438.4%  
Other income Rs m4084 46.8%   
Total revenues Rs m633220 287.9%   
Gross profit Rs m47-1,196 -3.9%  
Depreciation Rs m965 14.0%   
Interest Rs m145 251.7%   
Profit before tax Rs m64-1,183 -5.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m150-   
Profit after tax Rs m49-1,183 -4.2%  
Gross profit margin %7.9-883.6 -0.9%  
Effective tax rate %22.80-   
Net profit margin %8.3-873.5 -0.9%  
BALANCE SHEET DATA
Current assets Rs m4873,455 14.1%   
Current liabilities Rs m2951,050 28.1%   
Net working cap to sales %32.31,776.0 1.8%  
Current ratio x1.63.3 50.1%  
Inventory Days Days43,948 0.1%  
Debtors Days Days57,912,589218 26,605,900.1%  
Net fixed assets Rs m8351,373 60.8%   
Share capital Rs m180218 82.6%   
"Free" reserves Rs m6233,535 17.6%   
Net worth Rs m8043,753 21.4%   
Long term debt Rs m1630-   
Total assets Rs m1,3224,828 27.4%  
Interest coverage x5.7-218.8 -2.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.40 1,601.2%   
Return on assets %4.7-24.4 -19.5%  
Return on equity %6.1-31.5 -19.4%  
Return on capital %8.0-31.4 -25.5%  
Exports to sales %42.140.4 104.2%   
Imports to sales %13.6839.8 1.6%   
Exports (fob) Rs m25055 456.9%   
Imports (cif) Rs m811,137 7.1%   
Fx inflow Rs m25055 456.9%   
Fx outflow Rs m861,137 7.6%   
Net fx Rs m164-1,082 -15.1%   
CASH FLOW
From Operations Rs m237-1,031 -23.0%  
From Investments Rs m-383-2,606 14.7%  
From Financial Activity Rs m2103,955 5.3%  
Net Cashflow Rs m64317 20.1%  

Share Holding

Indian Promoters % 23.6 69.6 33.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 0.0 0.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 30.4 251.1%  
Shareholders   69,723 74,003 94.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GENNEX LABORATORIES vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs Suven Life Sciences Share Price Performance

Period GENNEX LABORATORIES Suven Life Sciences S&P BSE HEALTHCARE
1-Day 1.35% 0.30% 1.18%
1-Month -13.90% -2.06% -0.75%
1-Year 189.91% 114.92% 61.82%
3-Year CAGR 62.78% 14.94% 18.16%
5-Year CAGR 40.09% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.